Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114520-114520
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1458-1458
Open Access | Times Cited: 8
Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
Yishan Lu, Danyi Ao, Xuemei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology
Arthur Wickenhagen, Meaghan Flagg, Julia R. Port, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
4D-DIA Proteomics Uncovers New Insights into Host Salivary Response Following SARS-CoV-2 Omicron Infection
Iasmim Lopes de Lima, Thaís Regiani Cataldi, Carlos Brites, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 499-514
Open Access
In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models
Peilan Wei, Ruoxi Cai, Lu Zhang, et al.
Emerging Microbes & Infections (2025)
Open Access
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
H. J. Yang, Xuemei He, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S. Suthar, Kelly E. Manning, Madison L Ellis, et al.
The Lancet Infectious Diseases (2025)
Closed Access
Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants
Soojeong Chang, Jieun Shin, Seowoo Park, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Neutralizing antibody responses to three XBB protein vaccines in older adults
Guo‐Jian Yang, Mei Lu, Rui-Rui Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Mutational Scanning and Binding Free Energy Computations of the SARS-CoV-2 Spike Complexes with Distinct Groups of Neutralizing Antibodies: Energetic Drivers of Convergent Evolution of Binding Affinity and Immune Escape Hotspots
Mohammed Alshahrani, V S Parikh, Brian Foley, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1507-1507
Open Access
Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19
Yuto Unoh, Keiichiro Hirai, Shota Uehara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera
Kun Xu, Yaling An, Xueyuan Liu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike Protein
Zi‐Qi Feng, Jiachen Huang, Sabyasachi Baboo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Tracking KP.2 SARS-CoV-2 Variant in India and the Clinical Profile of KP.2 Cases in Maharashtra, India
Rajesh Karyakarte, Rashmita Das, Varsha Potdar, et al.
Cureus (2024)
Open Access | Times Cited: 1
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
Constant Gillot, Clara David, Jean-Michel Dogné, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Open Access | Times Cited: 1
Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS‐CoV‐2
Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu
Advances in Virology (2024) Vol. 2024, Iss. 1
Open Access
Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA
A Sakai, Gagandeep Singh, Mahsa Khoshbakht, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102331-102331
Open Access
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Decker, Sebastian Schulz, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1236-1236
Open Access
Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data
Miao Miao, Yonghong Ma, Jiao Tan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes
Ksenia V. Zornikova, Dmitry V. Dianov, Nataliia O Ivanova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12591-12591
Open Access
Page 1 - Next Page

Scroll to top